(To receive weekly emails of conversations with the world’s top CEOs and decisionmakers, click here.) It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to ...

27.1-fluid ounces of Johnson's Mild Baby Moisturizing Pink Lotion with coconut oil hydrates and nourishes your little one's skin and moisturizes to help maintain baby's healthy-looking skin The ...

Johnson & Johnson is a holding company ... Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas ...

SKIP AHEAD How we picked the best baby shampoos | The best baby shampoos of 2025 | Can you use a regular shampoo on a baby? | Why trust NBC Select? Want more from NBC Select? Sign up for our ...

Carrie Johnson recently stayed out of the public eye as she battled pneumonia, but following her recovery, she has now been throwing herself into activities with her children. On Saturday ...

High-rolling investors have positioned themselves bearish on Johnson & Johnson JNJ, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga ...

Supported by operational growth of 6.7%, Johnson & Johnson (JNJ, Financials) reported a 5.3% rise in fourth-quarter revenues to $22.5 billion. With operational growth of 5.9% except for COVID-19 ...

If you’re also looking to achieve a fuller, thicker mane this season, you may want to consider trying the RootStim Biotin and Rosemary Hair Growth Shampoo ... “lots of new baby hairs ...

Gabby Jones / Bloomberg / Getty Images Johnson & Johnson is scheduled to report fourth-quarter earnings Wednesday morning, with analysts expecting sales and profits to grow year-over-year.

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the ...

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...

Johnson & Johnson (NYSE:JNJ) is scheduled to announce Q4 earnings results on Wednesday, January 22nd, before market open. Analysts expect a profit per share of $2.02, which is a decline of 11.8% ...